Clinical Trial

A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the PK comparability and compare safety and tolerability of DRL\_AB administered via an auto injector (AI) or prefilled syringe (PFS) in healthy male participants.
Trial Details
NCT Number NCT07744828
Lead Sponsor Dr. Reddy's Laboratories Limited
Conditions Healthy Volunteers
Enrollment 160 participants
Start Date 2026-08-19
Primary Completion 2026-12-29 (estimated)
Study Completion 2026-12-29 (estimated)
Updated on ClinicalTrials.gov 2026-08-04